Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 14 Issue 2, February 2018

The cover depicts infection of an Arabidopsis plant by the fungus Botrytis cinerea. Jasmonylisoleucine is a phytohormone that regulates plant defense against fungal pathogens and whose synthesis was thought to be dependent on OPDA reductase 3 (OPR3) activity. An OPR3-indendent pathway was identified that produces 4,5-didehydrojasmonate as a precursor for jasmonyl-isoleucine. Cover design by Erin Dewalt, based on an image taken by Andrea Chini. Article, p171; News & Views, p109

Commentary

  • The central dogma processes of DNA replication, transcription, and translation are responsible for the maintenance and expression of every gene in an organism. An orthogonal central dogma may insulate genetic programs from host regulation and allow expansion of the roles of these processes within the cell.

    • Chang C Liu
    • Michael C Jewett
    • Chris A Voigt
    Commentary

    Advertisement

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • By integrating metagenomics, spectroscopy and synthetic biology, the individualized chemistry of small reef-dwelling organisms and their associated microbiota can be characterized in exquisite detail, unlocking a wealth of structural diversity for the development of new drugs.

    • Jack R Davison
    • Carole A Bewley
    News & Views
  • The lipid-derived hormone jasmonate promotes durable resistance of plants to a myriad of herbivores and pathogens. New evidence reveals an alternative pathway for the terminal steps of jasmonate biosynthesis and further advances our understanding of bioactive oxylipins in the plant kingdom.

    • Gregg A Howe
    News & Views
  • A potent and specific small-molecule inhibitor of a long-sought-after anticancer drug target, USP7, that acts allosterically to inhibit MDM2-stabilizing activity foretells of more allosteric inhibitors for deubiquitinases and E3 ligases.

    • Wei Zhang
    • Sachdev S Sidhu
    News & Views
Top of page ⤴

Article

Top of page ⤴

Erratum

Top of page ⤴

Search

Quick links